GnRH receptor antagonists for prostate cancerPatrick, Emily; Whitson, Melissa; Smith, Amy; Parnell, Jamin; Thomas, Suzanne E. PhD; Blankenship, Clint C. PharmD, PA-CJournal of the American Academy of Physician Assistants: July 2013 - Volume 26 - Issue 7 - p 51–52 doi: 10.1097/01.JAA.0000431511.13196.28 What's New in Oncology Abstract Author Information ABSTRACT GnRH receptor antagonists can reduce testosterone levels without the adverse reactions caused by other drugs used to treat prostate cancer. These drugs also offer hope for prolonged control of metastasis. Emily Patrick, Melissa Whitson, Amy Smith, and Jamin Parnell are students in the PA program at the Medical University of South Carolina in Charleston. Suzanne Thomas is a professor of research methods at the Medical University of South Carolina. Clint Blankenship is an assistant professor and academic coordinator of the PA program at the Medical University of South Carolina. The authors have indicated no relationships to disclose relating to the content of this article. Mark E. Archambault, DHSc, PA-C, department editor © 2013 American Academy of Physician Assistants.